NJ Momentum Fund
The scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related instruments of companies that exhibit strong momentum.
Growthvine rating: 1/5 — ranked #182 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.06 (as of 2026-11-17) |
|---|
| AUM | ₹365 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dhaval Patel |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −11.07% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 27.9% |
|---|
| Mid cap | 39.7% |
|---|
| Small cap | 32.4% |
|---|
Concentration
| Top 5 holdings | 23.6% |
|---|
| Top 10 holdings | 40.5% |
|---|
| Total holdings | 40 |
|---|
Top holdings
- Welspun Corp Limited — 6.0%
- Laurus Labs Limited — 5.3%
- Multi Commodity Exchange of India Ltd — 4.7%
- Titan Company Limited — 3.8%
- Federal Bank Ltd. — 3.7%
- Torrent Pharmaceuticals Ltd. — 3.6%
- Kirloskar Oil Engines Limited — 3.5%
- Lupin Ltd — 3.3%
- Bharat Forge Ltd — 3.3%
- ACUTAAS CHEMICALS LIMITED — 3.2%
Top sectors
- Pharma & Biotech — 21.8%
- Banking & Financial — 18.6%
- Industrial Products — 16.5%
Calendar-year track record
No calendar-year history.